Selten Pharma (Worldwide Development & Commercialization Rights Of BMPR2) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Selten Pharma (Worldwide Development & Commercialization Rights Of BMPR2) General Information

Description

Exclusive, worldwide rights for the development and commercialization of BMPR2 activators for the treatment of PAH and related vascular diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • United States
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Drug Discovery
Acquirer
Vivus
Corporate Office
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Selten Pharma (Worldwide Development & Commercialization Rights Of BMPR2) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Selten Pharma (Worldwide Development & Commercialization Rights Of BMPR2)‘s full profile, request access.

Request a free trial

Selten Pharma (Worldwide Development & Commercialization Rights Of BMPR2) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Selten Pharma (Worldwide Development & Commercialization Rights Of BMPR2)‘s full profile, request access.

Request a free trial

Selten Pharma (Worldwide Development & Commercialization Rights Of BMPR2) FAQs

  • Where is Selten Pharma (Worldwide Development & Commercialization Rights Of BMPR2) headquartered?

    Selten Pharma (Worldwide Development & Commercialization Rights Of BMPR2) is headquartered in .

  • What industry is Selten Pharma (Worldwide Development & Commercialization Rights Of BMPR2) in?

    Selten Pharma (Worldwide Development & Commercialization Rights Of BMPR2)’s primary industry is Buildings and Property.

  • Is Selten Pharma (Worldwide Development & Commercialization Rights Of BMPR2) a private or public company?

    Selten Pharma (Worldwide Development & Commercialization Rights Of BMPR2) is a Private company.

  • What is the current valuation of Selten Pharma (Worldwide Development & Commercialization Rights Of BMPR2)?

    The current valuation of Selten Pharma (Worldwide Development & Commercialization Rights Of BMPR2) is .

  • What is Selten Pharma (Worldwide Development & Commercialization Rights Of BMPR2)’s current revenue?

    The current revenue for Selten Pharma (Worldwide Development & Commercialization Rights Of BMPR2) is .

  • Who are Selten Pharma (Worldwide Development & Commercialization Rights Of BMPR2)’s investors?

    Selten Pharma has invested in Selten Pharma (Worldwide Development & Commercialization Rights Of BMPR2).

  • When was Selten Pharma (Worldwide Development & Commercialization Rights Of BMPR2) acquired?

    Selten Pharma (Worldwide Development & Commercialization Rights Of BMPR2) was acquired on 06-Jan-2017.

  • Who acquired Selten Pharma (Worldwide Development & Commercialization Rights Of BMPR2)?

    Selten Pharma (Worldwide Development & Commercialization Rights Of BMPR2) was acquired by Vivus.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process